The carrier solvent is toxic, and since the drug is cleared rapidly, it must be administered several times each day. Ketoconazole was the first orally absorbed azole shown Ketoconazole to have is often activity effective against C immitis. in extrameningeal.
Flu- itra- & ketoconazole Voriconazole & M. Cavling Arendrup posaconazole.
DESCRIPTION AND NOMENCLATURE OF CRRT Several methods of CRRT exist, and there is inconsistency in the literature regarding nomenclature. For this review, we will use the following terms: continuous arteriovenous hemofiltration CAVH ; , continuous venovenous hemofiltration CVVH ; , continuous arteriovenous hemodialysis CAVHD ; , continuous venovenous hemodialysis CVVHD ; , and continuous venovenous hemodialfiltration CVVHDF ; . These are consistent with the definitions established by an international conference on CRRT [2]. The most common modalities currently used in intensive care units are CVVH, CVVHD, and CVVHDF [3]. During CVVH, solute elimination is through convection, whereas CVVHD utilizes diffusion gradients through counter000 CID 2005: 41 15 October ; CLINICAL PRACTICE.
I can't sugest to someone to ignore medical advice even where i think it's poor, for example, ketoconazole half life.
The design of this study was based on the design of a previous WHO GPA study conducted at the same clinical site in Uganda. The WHO GPA study was meant to compare various topical and systemic antifungal treatments nystatin, miconazole gel, ketoconazole, and ketoconazole plus acid ; and to mimic "real-world" use of antifungals in developing countries. In the current open randomized, comparative, phase IIIb trial in presumed HIV-seropositive subjects with oropharyngeal candidiasis, subjects were randomized to receive either topical therapy using a 10-mg miconazole nitrate mucoadhesive buccal tablet once daily or systemic therapy using 400 mg of ketoconazole once daily for 7 consecutive days. The clinical response rate at day 7 and at the end of treatment demonstrated that miconazole nitrate was not significantly inferior to ketoconazole. At the end of treatment, the clinical response rate was 155 167 93% ; for miconazole nitrate and 159 165 96% ; for ketoconazole. Signs and symp.
Haram Alkawal is a village settled by Musalit. During the crisis, on February 2004, all the people fled to Habila. A few months later, on May 2004, people started to come back and in Haram Alkawal many families of returnees settled - Musalit tribe - in transit to Dalso, Salca, Tembaly, Sidool and Killa Farik. Sectoral issues. Health: nearest PHC in Habila 4km ; . Education: nearest primary school in Habila. Water: one h.p. working, one traditional well that needs to be cleaned. Food: people are registered for WFP distributions and lamisil.
I political the following 90-tablet discount enormously and effectively to alt.
2.4.2.4 Specific surface areas Specific surface areas of raw drug and three representative SAS powders are listed in Table 2.7. SAS 54 and 37 powders consisted of acicular drug crystals with and without spherical polymer coating. SAS 52 is a typical LM4156 PVP K17 solid dispersion with dense irregular particles. However processed powders exhibited low specific surface areas. Measured values did not reach the lower measuring limit of the instrument 1 m2 g and lansoprazole, because ketoconazole ointment.
It is especially important to check with your doctor before combining repaglinide with airway-opening medications such as alupent, proventil, and ventolin ; , alcohol excessive amounts can cause low blood sugar ; , aspirin, barbiturates such as the sedatives seconal and nembutal ; , beta blockers such as the blood pressure medications inderal and tenormin ; , blood thinners such as dicumarol and miradon ; , calcium channel blockers such as the blood pressure medications cardizem and procardia ; , carbamazepine tegretol ; , chloramphenicol chloromycetin ; , erythromycin eryc, ery-tab, pce ; , estrogens such as premarin ; , ketoconazole nizoral ; , furosemide lasix ; , glucose lowering agents such as glucotrol and micronase ; , isoniazid, major tranquilizers such as mellaril and stelazine ; , mao inhibitors such as the antidepressants marplan, nardil, and parnate ; , niacin nicobid ; , nonsteroidal anti-inflammatory drugs such as advil, motrin, naprosyn, and voltaren ; , oral contraceptives, phenytoin dilantin ; , probenecid benemid, colbenemid ; , rifampin rifadin, rimactane ; , steroids such as prednisone ; , sulfa drugs such as gantanol ; , thyroid medications such as synthroid ; , or water pills such as the thiazide diuretics dyazide and hydrodiuril.
Alcohol, because its muscle relaxing properties may worsen this condition. Sleeping tablets may also worsen sleep apnea by depressing the drive to breathe. Caffeine Eating late at night and levofloxacin.
The following are examples of drugs known to inhibit the metabolism of alprazolam and or related benzodiazepines, presumably through inhibition of CYP3A. Potent CYP3A Inhibitors Azole antifungal agents-- Ketoconazole and itraconazole are potent CYP3A inhibitors and have been shown in vivo to increase plasma alprazolam concentrations 3.98 fold and 2.70 fold, respectively. The coadministration of alprazolam with these agents is not recommended. Other azole-type antifungal agents should also be considered potent CYP3A inhibitors and the coadministration of alprazolam with them is not recommended see CONTRAINDICATIONS ; . Drugs demonstrated to be CYP3A inhibitors on the basis of clinical studies involving alprazolam caution and consideration of appropriate alprazolam dose reduction are recommended during coadministration with the following drugs ; Nefazodone -- Coadministration of nefazodone increased alprazolam concentration two-fold. Fluvoxamine -- Coadministration of fluvoxamine approximately doubled the maximum plasma concentration of alprazolam, decreased clearance by 49%, increased half-life by 71%, and decreased measured psychomotor performance. Cimetidine -- Coadministration of cimetidine increased the maximum plasma concentration of alprazolam by 86%, decreased clearance by 42%, and increased half-life by 16%. Other drugs possibly affecting alprazolam metabolism Other drugs possibly affecting alprazolam metabolism by inhibition of CYP3A are discussed in the PRECAUTIONS section see PRECAUTIONSDrug Interactions ; . PRECAUTIONS General Suicide As with other psychotropic medications, the usual precautions with respect to administration of the drug and size of the prescription are indicated for severely depressed patients or those in whom there is reason to expect concealed suicidal ideation or plans. Panic disorder has been associated with primary and secondary major depressive disorders and increased reports of suicide among untreated patients. Mania Episodes of hypomania and mania have been reported in association with the use of alprazolam in patients with depression. Uricosuric Effect Alprazolam has a weak uricosuric effect. Although other medications with weak uricosuric effect have been reported to cause acute renal failure, there have been no reported instances of acute renal failure attributable to therapy with alprazolam.
Infant exposure to ketoconazole in human milk was calculateci to be 0.4% on average maximum 1.4% ; o f those expected from therapeutic doses given directly to infants. Potentiai risks of adverse reaetlons h m this low exposure level seem to be outweighed by the benof breast-feeding. AMJ O m GYNECOL 1995: 173: 1625-6 and lexapro.
Buy cheap Ketoconazole online
Plastic surgery. 2. On March 19, 1988, "The Hoefflin Building", located at 1530 Arizona Avenue, Santa Monica, California, which was designed under direct supervision of Steven M. Hoefflin, M.D., was utilized as a model for outpatient surgicenter by the American Society of Outpatient Surgeons during that society's annual meeting. On March 14, 1989, Dr. Hoefflin hosted plastic surgical residents from UCLA Medical Center where operation of a plastic surgical office was discussed. On May 1, 1990, Dr. Hoefflin again hosted plastic surgical residents from UCLA Medical Center where operation of a plastic surgical office was discussed. Dr. Hoefflin was consultant to the Michael J. Fox plastic surgery movie, "Doc Hollywood", filmed in 1991. Dr. Hoefflin personally made arrangements for Lee Iacocca, Chief Executive Officer, Chairman of the Board, Chrysler Corporation, to deliver a speech at the Twenty-Fifth Annual Meeting of The American Society for Aesthetic Plastic Surgery, Inc., May 6, 1992. On February 6, 1994, the American Cinema Awards honored Dr. Hoefflin with the Joel McCrea Achievement Award. On April 8, 1994, the Southern California Motion Picture Council honored Dr. Hoefflin with the Golden Star Halo Award for his outstanding achievement as a plastic surgeon and his contribution in the entertainment industry. On October 3, 1995, Betsy Sharkey of Town and Country Magazine interviewed Dr. Hoefflin and discussion was had concerning breast implants and new plastic surgery techniques which included laser therapy. Dr. Hoefflin serves on the advisory board for renowned fitness trainer Jake Steinfeld's health and fitness magazine, Body By Jake, which premiered in April May 1997.
Military Dermatology 10. Joly J, Delage G. Auger P, Ricard P. Favus: Twenty cases of indigenous cases in the province of Quebec. Arch Dermatol. 1978; 114: 16471648. Allen AM, Taplin D. Epidemic Trichophyton mentagrophytes infections in servicemen: Source of infection, role of environment, host factors, and susceptibility. JAMA. 1973; 226: 864867. Gentry R, Tribelhorn D, Fitzpatrick JE. Atypical dermatophytosis acquired in the tropics. J Assoc Mil Dermatol. 1988; 14: 1718. Tanenbaum L, Taplin D, Lavelle C, Akers WA, Rosenberg MJ, Carmargo G. Sulconazole nitrate cream 1 percent for treating tinea cruris and corporis. Cutis. 1989; 44: 344347. Leyden JJ, Kligman AM. Interdigital athlete's foot: The interaction of dermatophytes and resident bacteria. Arch Dermatol. 1978; 114: 14661472. Andr J, Achten G. Onychomycosis. Int J Dermatol. 1987; 26: 481490. Lefler E, Haim S, Merzbach D. Evaluations of direct microscopic examination versus culture in the diagnosis of superficial fungal infections. Mykosen. 1981; 24: 102106. Loenenthal K. Seventy per cent ethyl alcohol as skin cleanser for fungus culture. Arch Dermatol. 1964; 89: 725729. Strauss JS, Kligman A. An experimental study of tinea pedis and onychomycosis of the foot. Arch Dermatol. 1957; 76: 7079. Lambert DR, Siegle RJ, Camisa C. Griseofulvin and ketoconazole in the treatment of dermatophyte infections. Int J Dermatol. 1989; 28: 300304. Allen HB, Honig PJ, Leyden JJ, McGinley KJ. Selenium sulfide: Adjunctive therapy for tinea capitis. Pediatrics. 1982; 69: 8183. Robertson MH, Rich P, Parker F, Hanifin JM. Ketoconazole in griseofulvin-resistant dermatophytosis. J Acad Dermatol. 1982; 6: 224229. VanDersarl JV, Sheppard RH. Clotrimazole vs haloprogin treatment of tinea cruris. Arch Dermatol. 1977; 113: 12331235. Zaias N, Battistini F, Gomez-Urcuyo F, Rojas RF, Ricart R. Treatment of "tinea pedis" with griseofulvin and topical antifungal cream. Cutis. 1978; 22: 196199. Leyden JJ, Kligman AM. Aluminum chloride in the treatment of symptomatic athlete's foot. Arch Dermatol. 1975; 111: 10041010. Qadripur SA, Horn G, Hhler T. Aur localwirksamkeit von ciclopiroxolamine bei nagelmykosen. Arzneim Forsch. 1981; 31: 13691372. Klaschka F. Treatment of onychomycosis with naftifine gel. Mykosen. 1987; 30 suppl 1 ; : 119123. Hersle K, Mobackern H, Moberg S. Long-term ketoconazole treatment of chronic acral dermatophyte infections. Int J Dermatol. 1985; 24: 245248. South DA, Farber EM. Urea ointment in the nonsurgical avulsion of nail dystrophies--A reappraisal. Cutis. 1980; 25: 609612. Dreizen S. Oral candidiasis. Amer J Med. 1984; 77 4D ; : 2833 and loratadine.
Before taking donepezil, tell your doctor if you are taking any of the following medicines: ketoconazole nizoral ; , fluconazole diflucan ; , or itraconazole sporanox quinidine cardioquin, quinidex, quinaglute, others phenytoin dilantin carbamazepine tegretol dexamethasone decadron ; , methylprednisolone medrol ; , prednisone deltasone, others ; , prednisolone prelone, pediapred, others ; , or another steroid; rifampin rifadin, rifamate, rifater ; or rifabutin mycobutin ; , or phenobarbital luminal, solfoton ; , pentobarbital nembutal ; , secobarbital seconal ; , or mephobarbital mebaral.
As part of an overall "Advance Clinical System" strategy, GBMC will continue to see projects of this nature moving more into the clinical setting and the ambulatory environment. "In the coming years, GBMC will continually add functionality and information to the EMR everything from radiology images to medication administration information would be included and, ideally, the ambulatory clinical visit records for patients seen in physician practices, " states Ms. Springmann. It is the integration of all this information that will provide true value of the EMR, she notes. "We will know we have arrived when all of the information any clinician at GBMC needs to care for his her patient is available and accessible through this tool and macrodantin.
View pubmed citation view isi citation publication history issue online: 10 feb 2006 received 15 july 2005, accepted 11 october 2005 home list of issues table of contents article abstract journal of clinical pharmacy and therapeutics volume 31 issue 1 page 99-109, february 2006 to cite this article: ismail pharmd, k, for example, ketoconazole 1.
Gynazole-1 Arrow Pharmaceuticals ; single dose applicator containing 5 g of cream Approved indication: local treatment of candidal vulvovaginitis Australian Medicines Handbook section 17 .11.1 Candida albicans is a common cause of vulvovaginitis.1, 2 These infections are usually treated with imidazole antifungal drugs. Butoconazole nitrate is the fifth imidazole agent to be registered in Australia, after clotrimazole, ketoconazole, miconazole and econazole. These drugs come in a number of different formulations including cream, pessaries and oral tablets ; and dosing regimens. Although butoconazole nitrate 2% cream is a new product in Australia, it was first introduced in the USA as a prescription drug in 1986 and is currently marketed there as an over-the-counter product. Depending on the formulation, up to 6% of an intravaginal dose is absorbed, with peak plasma levels being reached 1224 hours after administration. The drug is excreted mainly as metabolites in the urine and faeces. The Australian butoconazole cream has been formulated to adhere to the vaginal wall for longer than the standard butoconazole cream.3 The prolonged retention time means that this formulation can be given as a single-dose application rather than a three-day course. In a randomised open-label trial of 181 American women with vulvovaginal candidiasis, a single application of butoconazole cream was compared to a single 150 mg oral tablet of fluconazole. Twelve hours after treatment, 44.4% of women given topical butoconazole experienced first relief of symptoms and miconazole.
These results indicate that CYP3A4, CYP1A2, and CYP2D6 contribute 25 to 45% each to net clearance of MIR through all three metabolic pathways at anticipated in vivo liver MIR concentrations 2 M ; , while CYP2C8 and CYP2C9 account for less than 10% of MIR biotransformation. With increasing MIR concentrations, CYP3A4 contribution increases to 70% at 250 M MIR, while CYP2D6, CYP2C8, CYP2C9, and CYP1A2 account for less than 15% each Fig. 5d ; . Inhibition of Cytochromes P-450 by Mirtazapine. MIR concentrations equimolar to the concentration of index substrate 250 M ; reduced triazolam-4-hydroxylation reflecting CYP3A activity ; in HLM to 19% of control 5% S.D., n 4 ; . However, the IC50 value of MIR 37.1 36.9 M ; versus CYP3A was 3 orders of magnitude higher than that for ketoconazole 0.07 0.02 M ; , indicating only a modest inhibitory capacity of MIR. Index reactions reflecting CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP2E1 activity were not substantially affected Table 3 ; . Discussion In vitro incubations of MIR with human liver microsomes and recombinant CYP led to formation of OHM, DMM, and MNO Fig. 1 these represent the main MIR metabolites also found in vivo Delbressine and Vos, 1997; Delbressine et al., 1998 ; . Application of the relative activity factor approach Crespi and Penman, 1997; Venkatakrishnan et al., 1998 ; eq. 1 ; allowed quantitative predictions of the contribution of each enzyme to a particular pathway of MIR biotransformation. To apply these in vitro data to the situation in vivo, an estimation of intrahepatic drug concentrations in vivo is critical. Multiplication of plasma drug concentrations with a scaling factor reflecting partitioning of the drug from plasma into liver tissue Obach et al., 1997; von Moltke et al., 1998b; Schmider et al., 1999 ; provides an estimate of liver concentration. Two autopsy studies total number of 21 cases ; reported post-mortem liver MIR concentrations of 5- to 30-fold mean 10-fold ; higher than the concentration in peripheral blood Anderson et al., 1999; Moore et al., 1999 ; . Steady-state peak plasma MIR concentrations in a regimen of 15 to mg of MIR day range from 39 to 113 g l, equivalent to 0.1 to 0.4 mol l Timmer et al., 1995 ; . Based on the above-mentioned 10-fold difference between blood and liver concentration, we estimated liver MIR concentrations of 1 to mol l, which is reflected by the lowest MIR concentration of 2.5 M used in HLM in this study. The major in vitro metabolite at anticipated in vivo MIR concentrations was OHM, accounting for an average 60% of total MIR biotransformation Fig. 3 ; . DMM contributed about 30%, and a 10.
She has strategic smarts for aetna, home depot, pepsico and txu electric delivery and mirtazapine.
America was founded on concerns for freedom, not health.
Used as pain-killers, these drugs promote sedation, decrease anxiety, and produce a different perception of painful stimuli and monistat and ketoconazole, for example, ketoconazole shampoo.
100-300 mg tid-qid 100-300 mg bid; may induce heart failure. Two tabs once daily x 7-14 days. 250-500 mg qd; max 500 mg day; monitor blood count, liver function. Epilepsy: 250-500 mg tid-qid; monitor serum levels; hepatotoxic, pancreatitis. Mania: 250 mg tid, titrate to max 60 mg kg day in 3 divided doses. Migraine prophylaxis: 250 mg bid for 3 days, then 500 mg bid. 500-1000 mg once daily. 2.5-10 mcg kg min IV infusion; max of 14 mcg kg min Apply to affected areas x 10 days. Recurrent herpes labialis. 100 mg qd-tid 500 mcg bid if creatinine clearance 60 ml min, 250 mcg bid if Ccr 4060 ml min, 125 mcg bid if Ccr 20-39 ml min. Contraindicated if Ccr 20 ml min, QTc 440 mSec, or concomitant use with verapamil, cimetidine, trimethoprim, or ketoconazole. Reduce dose by 50% if the QTc 440 mSec or increases by 15% after the first dose. Dose-related QT prolongation. Does not reduce contractility. 5 mg qhs x 4-6 weeks, then 10 mg qhs. Less hepatotoxic than tacrine.
Ifampin is a potent inducer of cytochrome P-450 oxidative enzymes. A few examples of well-documented clinically significant interactions include interactions with warfarin, oral contraceptives, cyclosporine, glucocorticoids, ketoconazole or itraconazole, theophylline, quinidine sulfate, digitoxin or digoxin, verapamil hydrochloride, human immunodeficiency virusrelated protease inhibitors, zidovudine, delavirdine mesylate, nifedipine, and midazolam. Recent reports have demonstrated clinically relevant interactions with numerous other drugs, such as buspirone hydrochloride, zolpidem tartrate, simvastatin, propafenone hydrochloride, tacrolimus, ondansetron hydrochloride, and opiates. Rifabutin reduces serum concentrations of antiretroviral agents, but less so than rifampin. To avoid a reduced therapeutic response, therapeutic failure, or toxic reactions when rifampin is added to or discontinued from medication regimens, clinicians need to be cognizant of these interactions. Enhanced knowledge of known interactions will continue to develop, including research on the induction of specific cytochrome P-450 isoenzymes and on the importance of the P-glycoprotein transport system. New rifampin and rifabutin interactions will be discovered with further investigations. Arch Intern Med. 2002; 162: 985-992 and nabumetone.
Nearing parturition, plaintiff Christy Lee Johnston arrived on June 29, 1994 at the University of South Alabama Medical Center, a state-owned hospital. Dr. Felicia Stella, a fourth-year resident, and Dr. Scott Striplin, a first-year resident intern, helped deliver her daughter, Kaytlin Wimpee. As residents in training, both Dr. Stella and Dr. Striplin were working as employees of the state of Alabama. While in labor, Johnston was given a drug called Pitocin to aid in the delivery process. She claimed that the electronic devices monitoring the fetus indicated that the Pitocin be discontinued. The residents disagreed because they felt there was no evidence of fetal distress. According to Johnston, Dr. Stella initially informed her that a Cesarean section was required, and Johnston was moved to a delivery room where such a delivery could be performed. Once there, however, the child was delivered vaginally using a vacuum extractor. Within two hours of her birth, baby Kaytlin began experiencing seizures, which one physician ascribed to "perinatal asyphxia and ischemia, " or suffocation and decrease in the blood supply during birth. Kaytlin presently suffers from a seizure disorder and has motor defects on her left side. Johnston filed a medical malpractice action against Drs. Stella and Striplin. In particular, she contended that Kaytlin suffered serious injuries because the doctors negligently or wantonly.
Following systemic absorption, ezetimibe is extensively conjugated to a pharmacologically active phenolic glucuronide ezetimibe-glucuronide.
Unstable angina?" Controversies in Coronary Artery Disease, FA Davis Company, Philadelphia, 1982. Myler RK, Shaw RE, Stertzer SH, Zipkin RE, Hecht HS, Cumberland DC, Ryan C, Zapolanski A: "Complex and Complicated Coronary Artery Balloon Angioplasty. Diagnostic and Therapeutic Cardiac Catheterization. Pepine CJ, Hill JA, Lambert CR, Eds Williams & Wilkins, Baltimore, MD, 1994: pp 494-525. 3. Hecht HS. "Assessment of Cardiovascular Calcium: Interpretation and Relevance of Calcium Scoring and Relationship to Lipids and Other Cardiovascular Risk Factors" Computed Tomographic Imaging: Diagnosis of Cardiovascular Disease. Springer. 2006. Hecht HS. "CTA as an IVUS Equivalent: Plaque Characterization and PCI". Cardiovascular CT Imaging: Essentials for Clinical Practice. Springer 2007: In Press. 2.
Fig. 1. Effects of ketoconazole and cholestyramine resin ; on serum total sterols in a patient with prostate cancer. Cholestanol in terms of mmol mol of cholesterol; DHL, dihydrolanosterol.
Prescription Drugs
Differential effects on bone density and body composition in men with adultonset GH deficiency. J Clin Endocrinol Metab 85: 970 976 Colao A, Somma CD, Salerno M, Spinelli L, Orio F, Lombardi G 2002 The cardiovascular risk of GH-deficient adolescents. J Clin Endocrinol Metab 87: 3650 3655 Bjork S, Jonsson B, Westphal O, Levin JE 1989 Quality of life of adults with growth hormone deficiency: a controlled study. Acta Paediatr Scand Suppl 356: 5559 Rosen T, Wiren L, Wilhelmsen L, Wiklund I, Bengtsson B- 1994 Decreased psychological well-being in adult patients with growth hormone deficiency. Clin Endocrinol Oxf ; 40: 111116 Badia X, Lucas A, Sanmarti A, Roset M, Ulied A 1998 One-year follow-up of quality of life in adults with untreated growth hormone deficiency. Clin Endocrinol Oxf ; 49: 765771 Abs R, Bengtsson B, Hernberg-Stahl E, Monson JP, Tauber JP, Wilton P, Wuster C 1999 GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Clin Endocrinol Oxf ; 50: 703713 Sanmarti A, Lucas A, Hawkins F, Webb SM, Ulied A 1999 Observational study in adult hypopituitary patients with untreated growth hormone deficiency ODA study ; . Socio-economic impact and health status. Collaborative ODA Observational GH Deficiency in Adults ; Group. Eur J Endocrinol 141: 481 489 McGauley GA 1989 Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Paediatr Scand Suppl 356: 70 72 Bengtsson B, Eden S, Lonn L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Tolli J, Sjostrom L, Isaksson OG 1993 Treatment of adults with growth hormone GH ; deficiency with recombinant human GH. J Clin Endocrinol Metab 76: 309 317 Mrd G, Lundin K, Borg G, Jonsson B, Lindberg A 1994 Growth hormone replacement therapy in adult hypopituitary patients with growth hormone deficiency: combined data from 12 European placebo-controlled clinical trials. Endocrinol Metab 1 Suppl A ; : 43 Burman P, Broman JE, Hetta J, Wiklund I, Erfurth EM, Hagg E, Karlsson FA and lamisil.
Generic Ketoconazole
Prostate health is a typically overlooked problem in male health.
This bi-monthly newsletter aims to keep you updated on the Supply Initiative and related activities in ensuring essential reproductive health supplies. You can read the SupplyNews at : rhsupplies news news.shtml. Should you wish to include news, events or new resources relevant to the topic of supply shortages please write to the editor, Ms. Meghan Cloud at meghan.cloud rhsupplies. org.
|
|
|
